Pediatric Orthopedic and Spine Surgeon
About Dr. Raggio
Insurance
If your insurance is not listed, please call our office if you have questions regarding your insurance coverage. If you have out-of-network benefits, then your insurance may reimburse you for a portion of your office visit. We will work with you and your insurance to minimize your out-of-pocket costs. Financial assistance may be available for patients in need.
Credentials
Appointments
Attending Orthopedic Surgeon, Hospital for Special Surgery
Chair of the Osteogenesis Imperfecta (OI) Foundation Medical Advisory Council (MAC)
Assistant Professor of Clinical Orthopedic Surgery, Weill Cornell Medical College
Assistant Attending Orthopedic Surgeon, NewYork-Presbyterian Hospital
Affiliations
Orthopaedic Research Society
American Academy Orthopaedics Surgeons
Scoliosis Research Society
Pediatric Orthopaedic Society of North America
Osteogenesis Imperfecta Foundation
Maine Orthopaedic Review Course
American Society for Bone and Mineral Research
Certification
American Board of Orthopaedic Surgeons
Awards
Castle Connolly Top Doctors in New York Metro Area, 2021, 2022
New York Magazine Top Doctors, 2021, 2022
Long Island Center for Business & Professional Women, Award for Medicine, 1992
Residency Teaching Award, Long Island Jewish Medical Center, 1990-1991
T.J. Campbell Orthopedic Excellence Award, Cornell University Medical College, HSS, 1978
Phi Beta Kappa, Fordham University, 1974
Education
MD, Cornell University Medical College
Internship
The New York Hospital, New York, NY
Residency
Hospital for Special Surgery, New York, NY
Fellowship
Alfred I. DuPont Institute, Wilmington, Delaware
State Licensure
Languages
English
For My Patients
Publications by Dr. Raggio
Research
Clinical Trials / Research Studies
- The Kathryn O. and Alan C. Greenberg Center for Skeletal Dysplasias Clinical Research Registry
- A Randomized Double Blind Placebo Controlled Multi-Center Parallel Group Study of One Year Duration Followed by Two Years of open-label Treatment to Determine the Safety and Efficacy of Orally Administered 2.5 mg or 5.0 mg Daily Risedronate
Patient Registries
- Dr. Raggio is a principal investigator for these patient registries.
Industry Relationships
Industry Relationships
HSS has a long history of supporting appropriate relationships with industry because they advance HSS's mission to provide the highest quality patient care, improve patient mobility, and enhance the quality of life for all, and to advance the science of orthopedic surgery, rheumatology, and their related disciplines through research and education.
Below are the healthcare industry relationships reported by Dr. Raggio as of August 25, 2023.
- Biomarin - Consultant
- Nextcure - Research Support
- Osteogenesis Imperfecta Foundation - Advisory Board
- Sanofi- Consultant
HSS and its physicians make this information available to patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest and Commitment Policy prohibits physicians from collecting royalties on products they develop that are used on patients at HSS.
Patients should feel free to ask their HSS physicians questions about these relationships.